Search Results

• • 99 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies.

  Authors:Kayte Spector-Bagdady, Holly Fernandez Lynch, Barbara E. Bierer, Luke Gelinas, Sara Chandros Hull, David Magnus, et al.From:The Hastings Center Report (Vol. 52, Issue 1) Peer-Reviewed

  Jan-Feb 2022168 words Author abstract, Bri...

   Abstract Only

• The Role of Local Institutional Review Boards in Protecting Human Research Subjects

  Authors:William J. Burman, Robert T. Schooley, Michael A. Morse, Robert M. Califf, and Jeremy SugarmanFrom:JAMA, The Journal of the American Medical Association (Vol. 285, Issue 21) Peer-Reviewed

  June 6, 2001 Letter to the editor

   Citation Only

• Monitoring and Ensuring Safety During Clinical Research

  Authors:Michael A. Morse, Robert M. Califf, and Jeremy SugarmanFrom:JAMA, The Journal of the American Medical Association (Vol. 285, Issue 9) Peer-Reviewed

  Mar. 7, 200141 words Article

   Abstract Only

• Determining When Quality Improvement Initiatives Should Be Considered Research: Proposed Criteria and Potential Implications

  Authors:David Casarett, Jason H. T. Karlawish, and Jeremy SugarmanFrom:JAMA, The Journal of the American Medical Association (Vol. 283, Issue 17) Peer-Reviewed

  May 3, 200086 words Article

   Abstract Only

• Toward achieving meaningful consent in AIDS vaccine trials with injection-drug users

  Author:Jeremy SugarmanFrom:AIDS & Public Policy Journal (Vol. 9, Issue 4) Peer-Reviewed

  Winter 199473 words Article

   Citation Only

• Ethics and Medical Toxicology Research

  Authors:Jeremy Sugarman and Andrew StolbachFrom:Journal of Medical Toxicology (Vol. 13, Issue 3) Peer-Reviewed

  Sept. 2017 Article

   Citation Only

• Reflections on governance models for the clinical translation of stem cells

  Author:Jeremy SugarmanFrom:Journal of Law, Medicine & Ethics (Vol. 38, Issue 2) Peer-Reviewed

  Summer 20103,921 words Article 1760LA central promise of human embryonic stem cell research is the potential to develop viable therapeutic approaches to a range of devastating diseases and conditions. Despite excitement over such advances, there are...

• Ethics in human subjects research: do incentives matter?

  Authors:Ruth W. Grant and Jeremy SugarmanFrom:The Journal of Medicine and Philosophy (Vol. 29, Issue 6) Peer-Reviewed

  Dec. 2004193 words Author abstract

   Abstract Only

• Perceptions of HIV cure research among people living with HIV in Australia

  Authors:Jennifer Power, Andrew Westle, Gary W. Dowsett, Jayne Lucke, Joseph D. Tucker, Jeremy Sugarman, et al.From:PLoS ONE (Vol. 13, Issue 8) Peer-Reviewed

  Aug. 24, 20188,864 words Report 1480LParticipation in HIV cure-related clinical trials that involve antiretroviral treatment (ART) interruption may pose substantial individual risks for people living with HIV (PLHIV) without any therapeutic benefit. As...

• Bioethical challenges with HIV treatment as prevention

  Author:Jeremy SugarmanFrom:Clinical Infectious Diseases (Vol. 59, Issue 1) Peer-Reviewed

  July 1, 2014 Report

   Citation Only

• Bioethical considerations in developing a biorepository for the Pneumonia Etiology Research for Child Health Project

  Authors:Andrea N. DeLuca, Alan Regenberg, Jeremy Sugarman, David R. Murdoch, and Orin LevineFrom:Clinical Infectious Diseases (Vol. 54, Issue 7) Peer-Reviewed

  Apr. 1, 2012 Article

   Citation Only

• Realizing HOPE: the ethics of organ transplantation from HIV-positive donors

  Authors:Christine M. Durand, Dorry Segev, and Jeremy SugarmanFrom:Annals of Internal Medicine (Vol. 165, Issue 2) Peer-Reviewed

  July 19, 2016152 words Author abstract, Rep...

   Abstract Only

• Rethinking Human Embryo Research Policies

  Authors:Kirstin R. W. Matthews, Ana S. Iltis, Nuria Gallego Marquez, Daniel S. Wagner, Jason Scott Robert, Inmaculada Melo-Martin, et al.From:The Hastings Center Report (Vol. 51, Issue 1) Peer-Reviewed

  January-February 2021189 words Author abstract, Rep...

   Abstract Only

• Disclosure of cancer diagnosis and prognosis in Northern Tanzania

  Authors:Julian J. Harris, John Shao, and Jeremy SugarmanFrom:Social Science & Medicine (Vol. 56, Issue 5) Peer-Reviewed

  Mar. 2003246 words Abstract

   Abstract Only

• How the doctor got gagged: the disintegrating right of privacy in the physician-patient relationship

  Authors:Jeremy Sugarman and Madison PowersFrom:JAMA, The Journal of the American Medical Association (Vol. 266, Issue 23) Peer-Reviewed

  Dec. 18, 1991115 words Article

   Abstract Only

• Addressing ethical challenges in HIV prevention research with people who inject drugs

  Authors:Liza Dawson, Steffanie A. Strathdee, Alex John London, Kathryn E. Lancaster, Robert Klitzman, Irving Hoffman, et al.From:Journal of Medical Ethics (Vol. 44, Issue 3) Peer-Reviewed

  Mar. 2018250 words Author abstract, Rep...

   Citation Only

• Implementing post-trial access plans for HIV prevention research

  Authors:Amy Paul, Maria W. Merritt, and Jeremy SugarmanFrom:Journal of Medical Ethics (Vol. 44, Issue 5) Peer-Reviewed

  May 2018215 words Author abstract, Rep...

   Citation Only

• Ethics, oversight and quality improvement initiatives

  Authors:Holly A. Taylor, Peter J. Pronovost, and Jeremy SugarmanFrom:Quality and Safety in Health Care (Vol. 19, Issue 4) Peer-Reviewed

  Aug. 2010 Report

   Citation Only

• Physicians' Ethical Obligations Regarding Alternative Medicine

  Authors:Jeremy Sugarman and Larry BurkFrom:JAMA, The Journal of the American Medical Association (Vol. 280, Issue 18) Peer-Reviewed

  Nov. 11, 199896 words Article

   Abstract Only

• Ethics and policy issues for stem cell research and pulmonary medicine

  Authors:Justin Lowenthal and Jeremy SugarmanFrom:Chest (Vol. 147, Issue 3) Peer-Reviewed

  Mar. 2015 Report

   Citation Only